ArticleOphthalmology science
Artificial Intelligence Models to Identify Patients at High Risk for Glaucoma Using Self-reported Health Data in a United States National Cohort.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Detection of Glaucoma and Diabetic Retinopathy in Low-Resource Settings: Barriers and Solutions.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Purpose: Early glaucoma detection is key to preventing vision loss, but screening often requires specialized eye examination or photography, limiting large-scale implementation. This study sought to develop artificial intelligence models that use self-reported health data from surveys to prescreen patients at high risk for glaucoma who are most in need of glaucoma screening with ophthalmic examination and imaging. Design: Cohort study. Participants: Participants enrolled from May 1, 2018, to July 1, 2022, in the nationwide All of Us Research Program who were ≥18 years of age, had ≥2 eye-related diagnoses in their electronic health record (EHR), and submitted surveys with self-reported health history. Methods: We developed models to predict the risk of glaucoma, as determined by EHR diagnosis codes, using 3 machine learning approaches: (1) penalized logistic regression, (2) XGBoost, and (3) a fully connected neural network. Glaucoma diagnosis was identified based on International Classification of Diseases codes extracted from EHR data. An 80/20 train-test split was implemented, with cross-validation employed for hyperparameter tuning. Input features included self-reported demographics, general health, lifestyle factors, and family and personal medical history. Main Outcome Measures: Models were evaluated using standard classification metrics, including area under the receiver operating characteristic curve (AUROC). Results: Among the 8205 patients, 873 (10.64%) were diagnosed with glaucoma. Across models, AUROC scores for identifying which patients had glaucoma from survey health data ranged from 0.710 to 0.890. XGBoost achieved the highest AUROC of 0.890 (95% confidence interval [CI]: 0.860-0.910). Logistic regression followed with an AUROC of 0.772 (95% CI: 0.753-0.795). Explainability studies revealed that key features included traditionally recognized risk factors for glaucoma, such as age, type 2 diabetes, and a family history of glaucoma. Conclusions: Machine and deep learning models successfully utilized health data from self-reported surveys to predict glaucoma diagnosis without additional data from ophthalmic imaging or eye examination. These models may eventually enable prescreening for glaucoma in a wide variety of low-resource settings, after which high-risk patients can be referred for targeted screening using more specialized ophthalmic examination or imaging. Financial Disclosures: The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.